I have a passion for translating life science technologies into products and bringing together scientific breakthroughs and clinical applications to improve health and every aspect of life. Empowered by my love of science and commercialization of that science, I bridge technology and business by connecting people though my extensive network, in both academia and industry, and completing transactions to bring innovative technologies to the marketplace. I am constantly looking to the future to indentify pioneering science, especially in the areas of genetic analysis, gene editing and epigenetics, to guide the development of products in the here and now and assist companies to expand and succeed. I am a Molecular Biologist by training, but I've worn many hats in my career - strategist; corporate and business development; management of contract services, research collaborations and alliances; business leader; integration leader for mergers and acquisitions; marketing and product management; research and development - giving me a unique ability to see the big picture, lead multi-disciplinary projects and to navigate complex problems.
Oversaw the successful launch of Block-iT(TM) RNAi and Stealth RNAi(TM) product lines resulting in the 2004 Frost and Sullivan Excellence in Research Award
Head of Business Development September 2012 to CurrentCLONTECH LABORATORIES, A TAKARA BIO COMPANY － Mountain View, CAMountain View, CA Sept 2012-present Clontech Laboratories provides products and services that assist discovery and translational researchers in the advancement of their work. As a member of the Takara Bio Group, Clontech joins a company that holds a leadership position in the global life science market and is committed to improving the human condition through progress in biotechnology. Clontech's mission is to develop high-quality innovative products and services to accelerate discovery and innovation in life science. Head of Business Development Leads a team responsible for all technology acquisition, including in-licensing and M&A, and all out-licensing and OEM. I am also leading the company strategy for expansion into molecular diagnostics, including the supply of high quality DNA polymerases and enzymes for clinical applications and tests, as well as the identification of biomarkers for development of relevant disease specific panels utilizing our NGS technologies such as our SMART, SMARTer and SMART-seq 2 products for low input and single cell transcriptome analysis. * Manage all Corporate/Business Development including legal, transactions, communication and PR. * Developed partnerships and closed deals to exceed revenue growth goals for molecular and companion diagnostics. Finished 2013 at 120% to plan and 2014 at 144% to plan. * Administer out-licensing of company's fluorescent protein and other intellectual property. Met 10% revenue growth target in 2014. * Negotiated partnerships with NGS and other instrument providers for new products and applications of Clontech SMARTer RNA-seq products for low input, single cell assays. Employment Experience (continued)
Business Development and Marketing Consultant July 2009 to October 2012inGENEuity LIFE SCIENCE GROUP, LLC － San Clemente Beverly Potomac Falls Cambridge Tucson, CA MA VA AZLife Science consulting firm specializing in the strategy, business development and marketing needs of life science companies. Our firm utilizes our expertise in commercializing technologies, identifying markets and business opportunities that result in sustainable and profitable growth, to assist growing biotechnology businesses. Current and past clients include BGI Americas, RiboMed Biotechnologies, Enzymatics, TessArae, Covaris, Wafergen, Affymetrix, Gene Codes, Research Corporation Technologies (RCT), and others, in scientific areas including next-generation sequencing, genomics, infectious diseases, epigenetics, enzyme and protein production, DNA sequencing, sample prep, and molecular diagnostics. Selected inGENEuity Client Projects: RiboMed Biotechnologies, Inc., Carlsbad, CA RiboMed is an early-stage molecular diagnostic company, as well as a supplier of reagents and services to the translational research community, with an initial focus on epigenetic-based cancer diagnostics. RiboMed develops and commercializes innovative technologies for personalized medicine using their proprietary platform Abscription® * Wrote business plan, created investor pitch & presented to venture capital & investor groups. * Developed licensing programs negotiated license, OEM and strategic partnership agreements. * Created website for both RiboMed and RiboMed Clinical Services Laboratory. * Participated in the CLIA certification and launch of RiboMed's first DNA methylation laboratory developed test for glioma prognosis utilizing RiboMed's proprietary Abscription® platform technology. Enzymatics is a leading producer of reagents, kits, and assays that enable our customers worldwide to transform patient diagnosis, treatment, and life science research. Our business units include: Reagents, Supply Chain Solutions, Applied Science. * Consulting services contributed a 4X revenue growth in a 3-year period. * Designed logo and created style guides. * Developed slogan, value proposition and messaging. * Wrote website content, marketing collateral, marketing campaigns to create brand awareness promote value proposition, enhance customer experience, and SEO optimization. TessArae® is a next generation diagnostics company developing microarray-based tools and services for the simultaneous detection and definitive identification of hundreds of natural and emergent viral and bacterial pathogens, for medical and scientific research, and clinical diagnostics. * Market research and strategy development. Interviewed scientists, users and key opinion leaders. Helped company understand why its uniquely positioned technology was not gaining traction. Based on survey outcome, determined next steps to grow the company's business and expand market opportunity. Redirected company focus to genetic testing as primary and pathogen detection as secondary. * Update client's message, value proposition and positioning to better reflect its value proposition, key differentiators and key advantages. * Developed product names. * Marketing collateral and website content development to reflected new focus and value proposition. * In a short time, revenues from the genetic testing revenue quickly outpaced the pathogen testing revenue. Selected InGENEuity Clients (continued) BGI, the largest genomics center in the world, provides comprehensive sequencing and bioinformatics services for medical, agricultural and environmental applications. BGI helps their customers achieve their research goals by delivering rapid, high-quality results using a broad array of cost-effective, cutting-edge technologies. BGI customers also benefit from our scientific expertise and research experience that have generated over 600 publications, many in top-tier journals such as Nature and Science. BGI is recognized globally as an innovator for conducting international collaborative projects with leading research institutions to better mankind and our world. * Consultant to assist BGI transition from China to the US. Helped develop messaging and content specific to the US audience. * Market research and voice of customer survey. * Worked with Senior Management to determine corporate core values, company/technology benefits and encapsulate in Value Proposition that succinctly and powerfully captures the value specifically to the customer in the USA. * Re-designed website and developed messaging, slogans and content to portray the company's value to the US market. Research Corporation Technologies in Tucson, Ariz., is a technology investment and management company that provides early-stage funding and development for promising biomedical companies and technologies. RCT focuses on technology investments with origins from universities and research institutions worldwide. * Conducted technology and market opportunity assessment and made investment recommendations. * Created website, logo design, messaging and content for licensing of Pichia technology. * Created website, logo design, messaging and content for licensing of ClearColi technology. * SEO optimization for both Pichia and ClearColi technologies.
Interim Senior Director of Genetic Services May 2008 to June 2009SEQUENOM, INC － San Diego, CA
San Diego, CA May 2008-June 2009 Publicly held company specializing in providing genetic analysis products that translate results of genomic science into solutions for biomedical research, translational research and molecular diagnostics including proprietary SEQureDx® non-invasive pre-natal diagnostics. (Held two positions simultaneously) *Senior Director of Marketing and Product Management & **Interim Senior Director of Genetic Services *Sr. Director Marketing and Product Management, Genetic Analysis Division High profile Senior Director global P& L responsibility for $40M Genetic Analysis Division (100% of company's revenue at that time). Established business unit strategy including expansion to new markets including new product development. Steered tactical marketing including online marketing, MarCom activities and PR. * In collaboration with diagnostic marketing leader, initiated corporate Translational Medicine program, including corporate re-branding, new advertising campaign and licensing program, which capitalized on synergies across Genetic Analysis and Diagnostics business units and re-positioned the company to support corporate strategy and customer needs in LDT diagnostics segment. * Directed the launch of new products including OncoCARTA(TM) Cancer Profiling Panel; iSEQ(TM) Molecular Typing for surveillance, forensics and ID; SectroCHIP(TM) II; and MassARRAY® Compact 96 Instrument targeted for translational research and clinical services labs. * Developed and executed media and PR strategy for Genomic Analysis business unit. Managed relationships with external communications agencies and consultants. * Spearheaded market research and voice of customer surveys to improve product positioning, sales, and aid in the development of innovative multigenerational product development and marketing plans. Employment Experience (Sequenom - Continued) * Replaced single market approach and initiated three new vertical marketing campaigns and designed promotional strategy to drive growth in different market segments based on different customer needs * Introduced online marketing ad SEO initiatives that amplified web traffic and elevated organic search ranking from below top 100 to number 5 within a few months. **Interim Sr. Director, Genetic Services (concurrent position during search for new Genetic Services Director) Provided leadership to contract service organization for planning, designing, and execution of service opportunities, collaborations and strategic partnerships. Clients include pharma, diagnostics, animal and plant breeding companies and academic groups.
Led an integrated team of 20 to develop business models, standard descriptions of services offered, established performance targets and developed template contracts for partnership and service projects.
Established and implemented Services "Centers of Excellence" program.
Optimized the workload and workflow to achievelaboratory production, service revenue, and cost margin goals resulting in reduction of instrument repair and downtime by over 50% and increase in GM.
Corporate Development Manager February 2007 to May 2008APPLERA, APPLIED BIOSYSTEMS － Foster City Carlsbad, CAin life science industry and research community that develops and markets instrument-based systems, consumables, software, and services; with over 5000 employees Director of Licensing, Strategy and Business Development Group Director charged with conceiving and executing strategy for both in-and out-licensing activities to ensure attainment of business objectives for IP and licensing portfolio. * Managed the thermocycler out-licensing program. * Member of due diligence teams to evaluate M&A opportunities for business expansion, including next-gen sequencing technologies. * Supported legal department with patent enforcement activities. * Teamed with business units and legal to identify and assimilate external technologies and opportunities that positioned organization for continual growth and increased market share. * Initiated new out-licensing programs to capture value of ABI intellectual property portfolio. $1.2B publicly held company. Leading life science reagents, research kits and services provider - over 5000 employees Director who implemented methodologies to broaden OEM opportunities for Gene Expression Business Unit to molecular diagnostics, environmental testing, biodefense and other new markets. * Assessed new technology in-licensing and M&A opportunities for business leadership to maintain and expand market leadership position. Structured and negotiated deals. * Business Development lead for evaluation of gene expression and NGS technologies. Made recommendations and negotiated agreements in support of business strategy. * Instituted OEM and out-licensing strategy key IP assets and enzyme production and supply with a focus on molecular diagnostics. * Negotiated OEM terms to ensure business objectives were met. Marketing leader with global P&L responsibility for $30 million BioDiscovery Services Business Unit. Services included genomics, proteomics, custom peptides & antibodies, cell culture, cell line development and bioproduction. * Delivered immediate results by steering directives that altered three-year declining business trend and increased overall service revenue by 20% in year one. * Led product development and sales teams that launched and marketed global custom service solutions to biotech and pharma communities including RNAi, microRNA, antibodies and protein production. Employment Experience (Invitrogen - Continued) * Partnered with other business units and cross-functional teams to launch PD Direct (Process Development Direct) services allowing customers a full-solution from vector construction to scale-up and large-scale protein manufacturing. * Established a Project Management Organization (PMO) and implemented web based project management. * Six Sigma Champion for Green & Black Belt projects that reduced variation, increased service productivity, and refined costing models which positively impacted gross margins by as much as 15%. Senior Manager responsible for leading the integration of all aspects of acquired businesses into Invitrogen Corporation in addition to contributing to the long-term business strategy of business segment that included new products, services and technology acquisition. * Successfully lead integration of Sequitur into Invitrogen resulting in 1st year revenue exceeding the deal model. * Pioneered the development multi-generational product, services and technology advancement plan for RNAi business segment. * Oversaw the successful launch of Block-iT(TM) RNAi and Stealth RNAi(TM) product lines resulting in the 2004 Frost and Sullivan Excellence in Research Award. * Performed market research on technology and industry trends, customer needs and competitive activity and made recommendations to upper management. Responsible for identifying and assessing technology acquisition opportunities (in-licensing, out-licensing and M&A), potential strategic business partners and other new business opportunities as well as performing as key member of due diligence teams for evaluation of M&A opportunities. * Identified and negotiated the deal to acquire RNAi technology company Sequitur Inc. * Member of multiple M&A due diligence teams including Molecular Probes, Pan Vera, Quantum Dots, Xeotron and others. * Led cross-functional teams including legal, manufacturing, sales, marketing and R&D to progress and close targeted business transactions. * Negotiated numerous licensing, collaborative research, partnering, and M&A agreements.
Director of External Collaborations and Alliances January 1999 to July 2001GENEFORMATICS, INC － San Diego, CASan Diego, CA Jan 1999-Jul 2001 Privately held structural proteomics company that combined proprietary computational and experimental technology for the rapid elucidation of protein function Director of External Collaborations and Alliances Director responsible for negotiating and supervising collaborations and service contracts with partners in pharmaceutical, diagnostics, biotechnology and academic institutions. * Presented technology to potential partners and customers, investors, and at scientific conferences. * Partnered with R&D scientists and software engineering groups to advance bioinformatics products. * Wrote SBIR grants and negotiated terms for licensing and technology transfer opportunities. * Identified and evaluated new commercial and academic strategic alliance opportunities.
University of California San Diego － La Jolla, CA, USPostdoctoral Fellow, University of California San Diego, La Jolla, CA
Ph.D. : Molecular BiologyUniversity of Southern California － Los Angeles, CA, USPh.D. Molecular Biology, University of Southern California, Los Angeles, CA
Bachelor of Arts : BiologyCalifornia State University － Northridge, CA, USBachelor of Arts Biology, California State University, Northridge, CA AFFLIATIONS & PATENTS Member of the Board of Directors, RiboMed Biotechnologies, Inc. (June 2012 -present) Patent: US 6,544,740 Treatment of Endometriosis with Antileukoprotease Member: Licensing Executive Society
Strategic Business, Market & Sales Planning OEM and Supply Contracts Product Life Cycle Management Technology Evaluation and Due Diligence Team Building & Cross Functional Synergy Mergers and Acquisitions Creative Branding & Vertical Marketing Integration of Acquired Companies Marketing Communications and PR Services & Alliance Management New Product Development Contract Negotiation and Drafting Competitive Analysis, Positioning & Pricing
Services & Alliance Management New Product Development
Presented technology to potential partners and customers, investors, and at scientific conferences
Life Science, Marketing, Business Development, Biotechnology, Dna, M&a, Oem, Clients, And Marketing, Sequencing, Solutions, Progress, Genomics, New Products, Search Engine Optimization, Seo, Sales, Patent, Value Proposition, Intellectual Property, Pr, Public Relations, Contracts, Marketing Collateral, Laboratory, Due Diligence, Optimization, Market Research, Dna Sequencing, Bioinformatics, Patents, Brand Awareness, Product Awareness, Supply Chain, Exceed, Leads, Rna, B2b Software, Software Engineering, Business Plan, Clia, Product Development, Transmissions, Excellent Multitasker, Testing, Biomedical, Voice, Market Share, And Sales, Antibodies, Black Belt, Cell Culture, Cell Line, Large-scale, Million, Pmo, Process Development, Project Management, Six Sigma, Six-sigma, Steering, Web Based, Advertising, Branding, Consumer Surveys, Corporate Strategy, Customer Surveys, Forensics, Increase, Marcom, New Product Development, Online Marketing, Organic Search, Pr Strategy, Product Management, Product Positioning, Promotional, Public Relations Strategy, Simultaneously, Translate, Typing, Workflow, Environmental Testing, Gene Expression, Award, Integration, Integrator, Bacterial, Clinical Diagnostics, Content Development, Its, Natural, Simultaneous, Logo Design, Aspect, Competitive Analysis, Contract Negotiation, Drafting, Isis, Life Cycle, Marketing Communications, Mergers And Acquisitions, Pricing, Sales Planning, San, Storage Area Network, Team Building, Training, Translating, Benefits, Molecular Biology